High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours

Neuroendocrine Tumors

(2017)   Journal of the National Comprehensive Cancer Network

The Role of 68Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on 111In-DTPA-Octreotide Scintigraphy

(2010) R. Srirajaskanthan et al.   JOURNAL OF NUCLEAR MEDICINE

Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors

(2010) Dik J. Kwekkeboom et al.   SEMINARS IN NUCLEAR MEDICINE

Detection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT

(2009) Vikas Prasad et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy

(2009) D. Putzer et al.   JOURNAL OF NUCLEAR MEDICINE

ENETS Consensus Guidelines for the Standard of Care in Neuroendocrine Tumors

(2009) Ursula Plöckinger et al.   NEUROENDOCRINOLOGY

Clinical Utility of Hybrid SPECT-CT in Endocrine Neoplasia

(2008) Chirag N. Patel et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals

(2008) Melpomeni Fani et al.   Contrast Media & Molecular Imaging